advertisement
Archives of Ophthalmology 14
Showing records 1 to 14 | Display all abstracts in Archives of Ophthalmology5179 Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma.
Tezel G; Edward DP; Wax MB
Archives of Ophthalmology 1999; 117: 917-924
5200 Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma
Neufeld AH
Archives of Ophthalmology 1999; 117: 1050-1056
5304 A comparison of imaging techniques for diagnosing drusen of the optic nerve head
Kurz-Levin MM; Landau K
Archives of Ophthalmology 1999; 117: 1045-1049
5330 Optic nerve head morphologic characteristics in high-tension and normal-tension glaucoma
Iester M; Mikelberg FS
Archives of Ophthalmology 1999; 117: 1010-1013
5356 True exfoliation of the lens capsule
Karp CL; Fazio JR; Culbertson WW; Green WR
Archives of Ophthalmology 1999; 117: 1078-1080
5360 Correlation between age-related macular degeneration and pseudoexfoliation syndrome in the population of Crete (Greece).
Kozobolis VP; Detorakis ET; Tsilimbaris MK; Vlachonikolis IG; Tsambarlakis IC; Pallikaris IG
Archives of Ophthalmology 1999; 117: 664-669
5362 Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome.
Schumacher S; Nguyen NX; Kuechle M; Naumann GO
Archives of Ophthalmology 1999; 117: 733-735
5374 Treatment of malignant glaucoma with contact transscleral cyclophotocoagulation
Carassa RG; Bettin P; Fiori M; Brancato R
Archives of Ophthalmology 1999; 117: 688-690
5389 The Ocular Hypertension Treatment Study: design and baseline description of the participants.
Gordon MO; Kass MA
Archives of Ophthalmology 1999; 117: 573-583
5390 Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans (editorial; comment)
Kaufman PF
Archives of Ophthalmology 1999; 117: 673-674
5403 Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents (see comments)
Maus TL; Nau C; Brubaker RF
Archives of Ophthalmology 1999; 117: 586-591
5424 Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.
Sagara T; Gaton DD; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
Archives of Ophthalmology 1999; 117: 794-801
5470 Reaffirming the role of the laser in glaucoma management (editorial)
Higginbotham EJ
Archives of Ophthalmology 1999; 117: 1076
5509 Conjunctival advancement for late-onset filtering bleb leaks: Indications and outcomes
Budenz DL; Chen PP; Weaver YK
Archives of Ophthalmology 1999; 117: 1014-1019
